StockGlow

Valneva SE (VLA.PA)

Makes vaccines for diseases like Japanese encephalitis, cholera, and chikungunya.

2.19+0.02%Healthcare
Compare VLA.PA with
StockGlow Score
21
Leaning Bearish
BearishBullish
1 year ago-29.7%

The outlook

Valneva is trading well below its recent moving averages and sits near the lower end of its 52-week range, reflecting weak near-term momentum. Analyst coverage shows a notably bullish average price target roughly 139% above the current price, though the stock's StockGlow score leans bearish overall. The wide gap between the depressed price and target suggests either significant upside potential or a disconnect between analyst expectations and current market sentiment.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range5% of the way from its 52-week low to high
Price targetAvg target +139% vs current price

Analyst price target

~12-month · 6 analysts
5.23average target+138.7% vs now
Now 2.19
Low 2.10High 7.50

Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.

Market cap
$447.7M
52-wk high
5.42
52-wk low
2.03
50-day avg
2.31
200-day avg
3.36
Trailing P/E
—

Similar stocks

GNFT.PAGenfit S.A.$13.20-3.23%DBV.PADBV Technologies S.A.$2.37-2.79%IPH.PAInnate Pharma S.A.$1.60-1.23%NANO.PANanobiotix S.A.$32.84-6.81%VALNValneva SE$5.06+2.02%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy